Brown Advisory’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Brown Advisory's CLPT Position: Q2 2026 in Review
Brown Advisory held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 325,906 shares worth $5.81M. The position accounts for 0.01% of the portfolio, ranked #524.
Brown Advisory first reported a position in CLPT in Q3 2019 and has held it in 28 quarters since. The position peaked at $7.21M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Brown Advisory held 325,906 shares of ClearPoint Neuro worth $5.81M as of Q2 2026.
- Brown Advisory left its ClearPoint Neuro share count unchanged in Q2 2026.
- ClearPoint Neuro made up 0.01% of Brown Advisory's portfolio in Q2 2026, its #524 holding.
- Brown Advisory first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 28 quarters since.
- Brown Advisory's ClearPoint Neuro position peaked at $7.21M in Q3 2025.
- 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.